Evaluation of in silico predictors on short nucleotide variants in HBA1, HBA2 and HBB associated with haemoglobinopathies

  1. Stella Tamana
  2. Maria Xenophontos
  3. Anna Minaidou
  4. Coralea Stephanou
  5. Cornelis L Harteveld
  6. Celeste Bento
  7. Joanne Traeger-Synodinos
  8. Irene Fylaktou
  9. Norafiza Mohd Yasin
  10. Faidatul Syazlin Abdul Hamid
  11. Ezalia Esa
  12. Hashim Halim-Fikri
  13. Bin Alwi Zilfalil
  14. Andrea C Kakouri
  15. ClinGen Hemoglobinopathy VCEP
  16. Marina Kleanthous
  17. Petros Kountouris  Is a corresponding author
  1. Cyprus Institute of Neurology and Genetics, Cyprus
  2. Leiden University Medical Center, Netherlands
  3. Centro Hospitalar e Universitário de Coimbra, Portugal
  4. National and Kapodistrian University of Athens, Greece
  5. Ministry of Health Malaysia, Malaysia
  6. Universiti Sains Malaysia, Malaysia

Abstract

Haemoglobinopathies are the commonest monogenic diseases worldwide and are caused by variants in the globin gene clusters. With over 2400 variants detected to date, their interpretation using the ACMG/AMP guidelines is challenging and computational evidence can provide valuable input about their functional annotation. While many in silico predictors have already been developed, their performance varies for different genes and diseases. In this study, we evaluate 31 in silico predictors using a dataset of 1627 variants in HBA1, HBA2, and HBB. By varying the decision threshold for each tool, we analyse their performance (a) as binary classifiers of pathogenicity, and (b) by using different non-overlapping pathogenic and benign thresholds for their optimal use in the ACMG/AMP framework. Our results show that CADD, Eigen-PC, and REVEL are the overall top performers, with the former reaching moderate strength level for pathogenic prediction. Eigen-PC and REVEL achieve the highest accuracies for missense variants, while CADD is also a reliable predictor of non-missense variants. Moreover, SpliceAI is the top performing splicing predictor, reaching strong level of evidence, while GERP++ and phyloP are the most accurate conservation tools. This study provides evidence about the optimal use of computational tools in globin gene clusters under the ACMG/AMP framework.

Data availability

All data generated or analysed during this study are included in Supporting File 2 and Supporting File 3. Supporting File 2 provides the full dataset and subsets used as input in the analysis (sheet names starting with "Input") as well as the results of the analysis (sheets starting with "On"). Supporting File 3 includes the finetuning analysis for specific tools and data subsets, as described in the manuscript.We make the source code for evaluating the tools and generating the figures presented herein, freely available at https://github.com/cing-mgt/evaluation-of-in-silico-predictors.

Article and author information

Author details

  1. Stella Tamana

    Molecular Genetics Thalassaemia Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
    Competing interests
    The authors declare that no competing interests exist.
  2. Maria Xenophontos

    Molecular Genetics Thalassaemia Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5978-0193
  3. Anna Minaidou

    Molecular Genetics Thalassaemia Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
    Competing interests
    The authors declare that no competing interests exist.
  4. Coralea Stephanou

    Molecular Genetics Thalassaemia Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
    Competing interests
    The authors declare that no competing interests exist.
  5. Cornelis L Harteveld

    Leiden University Medical Center, Leiden, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  6. Celeste Bento

    Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
    Competing interests
    The authors declare that no competing interests exist.
  7. Joanne Traeger-Synodinos

    Laboratory of Medical Genetics, National and Kapodistrian University of Athens, Athens, Greece
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1860-5628
  8. Irene Fylaktou

    First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece
    Competing interests
    The authors declare that no competing interests exist.
  9. Norafiza Mohd Yasin

    Haematology Unit, Ministry of Health Malaysia, Selangor, Malaysia
    Competing interests
    The authors declare that no competing interests exist.
  10. Faidatul Syazlin Abdul Hamid

    Haematology Unit, Ministry of Health Malaysia, Selangor, Malaysia
    Competing interests
    The authors declare that no competing interests exist.
  11. Ezalia Esa

    Haematology Unit, Ministry of Health Malaysia, Selangor, Malaysia
    Competing interests
    The authors declare that no competing interests exist.
  12. Hashim Halim-Fikri

    Malaysian Node of the Human Variome Project, Universiti Sains Malaysia, Kelantan, Malaysia
    Competing interests
    The authors declare that no competing interests exist.
  13. Bin Alwi Zilfalil

    Human Genome Centre, Universiti Sains Malaysia, Kelantan, Malaysia
    Competing interests
    The authors declare that no competing interests exist.
  14. Andrea C Kakouri

    Molecular Genetics Thalassaemia Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
    Competing interests
    The authors declare that no competing interests exist.
  15. ClinGen Hemoglobinopathy VCEP

  16. Marina Kleanthous

    Molecular Genetics Thalassaemia Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
    Competing interests
    The authors declare that no competing interests exist.
  17. Petros Kountouris

    Molecular Genetics Thalassaemia Department, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
    For correspondence
    petrosk@cing.ac.cy
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2681-4355

Funding

Research and Innovation Foundation [Cyprus] (EXCELLENCE/1216/256)

  • Maria Xenophontos
  • Anna Minaidou
  • Bin Alwi Zilfalil
  • Marina Kleanthous
  • Petros Kountouris

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2022, Tamana et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,049
    views
  • 157
    downloads
  • 5
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Stella Tamana
  2. Maria Xenophontos
  3. Anna Minaidou
  4. Coralea Stephanou
  5. Cornelis L Harteveld
  6. Celeste Bento
  7. Joanne Traeger-Synodinos
  8. Irene Fylaktou
  9. Norafiza Mohd Yasin
  10. Faidatul Syazlin Abdul Hamid
  11. Ezalia Esa
  12. Hashim Halim-Fikri
  13. Bin Alwi Zilfalil
  14. Andrea C Kakouri
  15. ClinGen Hemoglobinopathy VCEP
  16. Marina Kleanthous
  17. Petros Kountouris
(2022)
Evaluation of in silico predictors on short nucleotide variants in HBA1, HBA2 and HBB associated with haemoglobinopathies
eLife 11:e79713.
https://doi.org/10.7554/eLife.79713

Share this article

https://doi.org/10.7554/eLife.79713

Further reading

    1. Computational and Systems Biology
    2. Medicine
    Xin Zhou, Zhinuo Jenny Wang ... Blanca Rodriguez
    Research Article

    Sudden death after myocardial infarction (MI) is associated with electrophysiological heterogeneities and ionic current remodelling. Low ejection fraction (EF) is used in risk stratification, but its mechanistic links with pro-arrhythmic heterogeneities are unknown. We aim to provide mechanistic explanations of clinical phenotypes in acute and chronic MI, from ionic current remodelling to ECG and EF, using human electromechanical modelling and simulation to augment experimental and clinical investigations. A human ventricular electromechanical modelling and simulation framework is constructed and validated with rich experimental and clinical datasets, incorporating varying degrees of ionic current remodelling as reported in literature. In acute MI, T-wave inversion and Brugada phenocopy were explained by conduction abnormality and local action potential prolongation in the border zone. In chronic MI, upright tall T-waves highlight large repolarisation dispersion between the border and remote zones, which promoted ectopic propagation at fast pacing. Post-MI EF at resting heart rate was not sensitive to the extent of repolarisation heterogeneity and the risk of repolarisation abnormalities at fast pacing. T-wave and QT abnormalities are better indicators of repolarisation heterogeneities than EF in post-MI.

    1. Computational and Systems Biology
    Alessandro Bitto
    Insight

    Measuring mitochondrial respiration in frozen tissue samples provides the first comprehensive atlas of how aging affects mitochondrial function in mice.